An official website of the United States government
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects the viability of upper and lower motor neurons. Current options for treatment are limited, necessitating deeper understanding of the mechanisms underlying ALS pathogenesis. Glycerophosphodiester phosphodiesterase 2 (GDE2 or GDPD5) is a six-transmembrane protein that acts on the cell surface to cleave the glycosylphosphatidylinositol (GPI)-anchor that tethers some proteins to the membrane. GDE2 is required for the survival of spinal motor neurons but whether GDE2 neuroprotective activity is disrupted in ALS is not known. We utilized a combination of mouse models and patient post-mortem samples to evaluate GDE2 functionality in ALS. Haplogenetic reduction of GDE2 exacerbated motor neuron degeneration and loss in SOD1 G93A mice but not in control SOD1 WT transgenic animals, indicating that GDE2 neuroprotective function is diminished in the context of SOD1 G93A . In tissue samples from patients with ALS, total levels of GDE2 protein were equivalent to healthy controls; however, membrane levels of GDE2 were substantially reduced. Indeed, GDE2 was found to aberrantly accumulate in intracellular compartments of ALS motor cortex, consistent with a disruption of GDE2 function at the cell surface. Supporting the impairment of GDE2 activity in ALS, tandem-mass-tag mass spectrometry revealed a pronounced reduction of GPI-anchored proteins released into the CSF of patients with ALS compared with control patients. Taken together, this study provides cellular and biochemical evidence that GDE2 distribution and activity is disrupted in ALS, supporting the notion that the failure of GDE2-dependent neuroprotective pathways contributes to neurodegeneration and motor neuron loss in disease. These observations highlight the dysregulation of GPI-anchored protein pathways as candidate mediators of disease onset and progression and accordingly, provide new insight into the mechanisms underlying ALS pathogenesis.
more »
« less
Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis
Abstract Bulbar deterioration in amyotrophic lateral sclerosis (ALS) is a devastating characteristic that impairs patients’ ability to communicate, and is linked to shorter survival. The existing clinical instruments for assessing bulbar function lack sensitivity to early changes. In this paper, using a cohort ofN = 65 ALS patients who provided regular speech samples for 3–9 months, we demonstrated that it is possible to remotely detect early speech changes and track speech progression in ALS via automated algorithmic assessment of speech collected digitally.
more »
« less
- Award ID(s):
- 1853247
- PAR ID:
- 10202411
- Publisher / Repository:
- Nature Publishing Group
- Date Published:
- Journal Name:
- npj Digital Medicine
- Volume:
- 3
- Issue:
- 1
- ISSN:
- 2398-6352
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Abstract Objective. Decoding neural activity from ventral (speech) motor cortex is known to enable high-performance speech brain-computer interface (BCI) control. It was previously unknown whether this brain area could also enable computer control via neural cursor and click, as is typically associated with dorsal (arm and hand) motor cortex. Approach. We recruited a clinical trial participant with ALS and implanted intracortical microelectrode arrays in ventral precentral gyrus (vPCG), which the participant used to operate a speech BCI in a prior study. We developed a cursor BCI driven by the participant’s vPCG neural activity, and evaluated performance on a series of target selection tasks. Main results. The reported vPCG cursor BCI enabled rapidly-calibrating (40 seconds), accurate (2.90 bits per second) cursor control and click. The participant also used the BCI to control his own personal computer independently. Significance. These results suggest that placing electrodes in vPCG to optimize for speech decoding may also be a viable strategy for building a multi-modal BCI which enables both speech-based communication and computer control via cursor and click. (BrainGate2 ClinicalTrials.gov ID NCT00912041)more » « less
-
Abstract Objective. Neurological disorders affecting speech production adversely impact quality of life for over 7 million individuals in the US. Traditional speech interfaces like eye-tracking devices and P300 spellers are slow and unnatural for these patients. An alternative solution, speech brain-computer interfaces (BCIs), directly decodes speech characteristics, offering a more natural communication mechanism. This research explores the feasibility of decoding speech features using non-invasive EEG.Approach. Nine neurologically intact participants were equipped with a 63-channel EEG system with additional sensors to eliminate eye artifacts. Participants read aloud sentences selected for phonetic similarity to the English language. Deep learning models, including Convolutional Neural Networks and Recurrent Neural Networks with and without attention modules, were optimized with a focus on minimizing trainable parameters and utilizing small input window sizes for real-time application. These models were employed for discrete and continuous speech decoding tasks.Main results. Statistically significant participant-independent decoding performance was achieved for discrete classes and continuous characteristics of the produced audio signal. A frequency sub-band analysis highlighted the significance of certain frequency bands (delta, theta, gamma) for decoding performance, and a perturbation analysis was used to identify crucial channels. Assessed channel selection methods did not significantly improve performance, suggesting a distributed representation of speech information encoded in the EEG signals. Leave-One-Out training demonstrated the feasibility of utilizing common speech neural correlates, reducing data collection requirements from individual participants.Significance. These findings contribute significantly to the development of EEG-enabled speech synthesis by demonstrating the feasibility of decoding both discrete and continuous speech features from EEG signals, even in the presence of EMG artifacts. By addressing the challenges of EMG interference and optimizing deep learning models for speech decoding, this study lays a strong foundation for EEG-based speech BCIs.more » « less
-
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that affects neurons in the brain and spinal cord, causing loss of muscle control, and eventually leads to death. Phosphorylated transactive response DNA binding protein‐43 (TDP‐43) is the major pathological protein in both sporadic and familial ALS, forming cytoplasmic aggregates in over 95% of cases. Of the 10–15% of ALS cases that are familial, mutations in TDP‐43 represent about 5% of those with a family history. We have developed anin vitrooverexpression model by introducing three familial ALS mutations (A315T, M337V, and S379P) in the TDP‐43 (TARDBP) gene which we define as 3X‐TDP‐43. This overexpression model TDP‐43 shows deficits in autophagy flux and colocalization of TDP‐43 with stress granules. We also observe a progressive shift of TDP‐43 to the cytoplasm in this model. This overexpression model shows a reduction in solubility of phosphorylated TDP‐43 from RIPA to urea soluble. Four glycolytic enzymes, phosphoglycerate kinase one (PGK1), aldolase A (ALDOA), enolase 1 (ENO1), and pyruvate dehydrogenase kinase 1 (PDK1) show significant time‐dependent decreases in 3X‐TDP‐43 expressing cells. Shotgun proteomic analysis shows global changes in the importin subunit alpha‐1 (KPNA2), heat shock 70 kDa protein 1A (HSPA1A), and protein disulfide‐isomerase A3 (PDIA3) expression levels and coimmunoprecipitation reveals that these proteins complex with TDP‐43. Overall, these results suggest that the 3X‐TDP‐43 model may provide new insights into pathophysiology and an avenue for drug screeningin vitrofor those suffering from ALS and related TDP‐43 proteinopathies.more » « less
-
Précis:The relationship between structural and hemodynamic parameters in patients with primary open angle glaucoma is strongest in the temporal region of the optic nerve. Purpose:To investigate the relationship between radial peripapillary capillary (RPC) vessel density (VD) and retinal nerve fiber layer (RNFL) thickness in quadrants and sectors of the optic nerve head (ONH) in patients with and without primary open angle glaucoma (POAG). Methods:In a cross-sectional prospective analysis, 191 subjects (80 early-stage POAG; 111 non-glaucomatous controls) were assessed for RNFL thickness and RPC VD in each quadrant [superior (S), inferior (I), nasal (N) and temporal (T)] and sector [inferior-temporal (IT), temporo-inferior (TI), temporo-superior (TS), superior-temporal (ST), inferior-nasal (IN), naso-inferior (NI), naso-superior (NS), and superior-nasal (SN) sectors] of the ONH through optical coherence tomography angiography (OCTA). Pearson correlations were used to test for associations between measurements, withP<0.05 considered statistically significant. Results:Significantly stronger positive correlations were found between RPC VD and RNFL thickness in the S, I, and T quadrants in POAG patients compared with non-glaucomatous controls (allP<0.05). The temporal quadrant in POAG patients displayed the largest difference in correlation compared with controls. A stronger positive correlation was also found between RPC VD and RNFL thickness in the temporal sectors of the ONH in POAG patients compared with controls, with the largest difference in the TS sector (allP<0.05). Conclusion:Early-stage POAG patients have a stronger relationship between RPC VD and RNFL in the temporal regions of the ONH compared with non-glaucomatous controls, with the TS sector demonstrating the largest difference between groups. Temporal sector VD loss may represent an early-stage biomarker for vascular-linked POAG disease.more » « less
